Efficacy and Safety Study of GPX-150 to Treat Soft Tissue Sarcoma

NCT02267083 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Soft Tissue Sarcoma

Interventions

DRUG: GPX-150 for Injection

Sponsor

Gem Pharmaceuticals